Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
$651M |
| 2 |
Monster Beverage
MNST
|
$615M |
| 3 |
Intercontinental Exchange
ICE
|
$556M |
| 4 |
Johnson & Johnson
JNJ
|
$382M |
| 5 |
Applied Materials
AMAT
|
$381M |
Top Sells
| 1 |
Lam Research
LRCX
|
$1.95B |
| 2 |
Texas Instruments
TXN
|
$771M |
| 3 |
Deere & Co
DE
|
$597M |
| 4 |
Meta Platforms (Facebook)
META
|
$543M |
| 5 |
Microsoft
MSFT
|
$510M |
Sector Composition
| 1 | Technology | 34.01% |
| 2 | Healthcare | 19.85% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Financials | 9.48% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVDL
201
Avadel Pharmaceuticals
AVDL
$1.46B
| $175M | 0.09% |
13,326,887
+29,570
| +0.2% | +$388K |
|
202
Mirum Pharmaceuticals
MIRM
$3.73B
| $175M | 0.09% |
4,480,284
-508,463
| -10% | -$19.8M |
|
203
Structure Therapeutics
GPCR
$1.14B
| $174M | 0.09% |
3,956,878
+602,609
| +18% | +$26.4M |
|
204
Dentsply Sirona
XRAY
$2.86B
| $173M | 0.09% |
6,389,767
-1,172,600
| -16% | -$31.7M |
|
205
Glaukos
GKOS
$5.17B
| $173M | 0.09% |
1,325,784
-131,749
| -9% | -$17.2M |
|
206
Capital One
COF
$145B
| $172M | 0.09% |
1,149,555
-40,527
| -3% | -$6.07M |
|
207
nVent Electric
NVT
$14.8B
| $171M | 0.09% |
2,441,154
+466,042
| +24% | +$32.7M |
|
208
Arcellx
ACLX
$4B
| $168M | 0.09% |
2,011,950
+109,332
| +6% | +$9.13M |
|
209
Apollo Global Management
APO
$77.1B
| $167M | 0.09% |
1,339,355
+4,892
| +0.4% | +$611K |
|
210
Xylem
XYL
$34.5B
| $167M | 0.09% |
1,239,550
-241,763
| -16% | -$32.6M |
|
211
United Therapeutics
UTHR
$17.2B
| $165M | 0.08% |
460,419
+50,409
| +12% | +$18.1M |
|
212
Western Alliance Bancorporation
WAL
$10.1B
| $164M | 0.08% |
1,896,377
+74,956
| +4% | +$6.48M |
|
213
IDEAYA Biosciences
IDYA
$2.26B
| $164M | 0.08% |
5,162,376
+1,086,356
| +27% | +$34.4M |
|
214
Chart Industries
GTLS
$8.96B
| $162M | 0.08% |
1,307,823
+41,079
| +3% | +$5.1M |
|
215
AXIS Capital
AXS
$7.76B
| $161M | 0.08% |
2,021,949
-281,011
| -12% | -$22.4M |
|
216
Williams Companies
WMB
$70.3B
| $158M | 0.08% |
3,468,826
-8,900
| -0.3% | -$406K |
|
217
Micron Technology
MU
$139B
| $157M | 0.08% |
1,516,256
+91,469
| +6% | +$9.49M |
|
218
Ziff Davis
ZD
$1.53B
| $156M | 0.08% |
3,214,600
+62,261
| +2% | +$3.03M |
|
219
Vanguard Total International Stock ETF
VXUS
$102B
| $154M | 0.08% |
2,379,351
-2,792
| -0.1% | -$181K |
|
220
Encompass Health
EHC
$12.5B
| $153M | 0.08% |
1,577,719
-2,665
| -0.2% | -$258K |
|
221
Marriott International Class A Common Stock
MAR
$73B
| $152M | 0.08% |
613,052
+47,551
| +8% | +$11.8M |
|
222
S&P Global
SPGI
$165B
| $150M | 0.08% |
289,480
+13,952
| +5% | +$7.21M |
|
223
Ardelyx
ARDX
$1.58B
| $148M | 0.08% |
21,529,880
-4,419,443
| -17% | -$30.4M |
|
224
Gilead Sciences
GILD
$140B
| $148M | 0.08% |
1,761,561
+98,067
| +6% | +$8.22M |
|
225
Public Storage
PSA
$51.3B
| $146M | 0.07% |
401,157
+3,935
| +1% | +$1.43M |
|